Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin maintenance therapy in primary ciliary dyskinesia
2013-004664-58Phase 3Terminated
- Sponsor
- Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary ciliary dyskinesia (PCD) comparing Azithromycin maintenance therapy with Placebo control (2 arms). Primary endpoint: Respiratory system exacerbations. Started Apr 2014; status: terminated.
02
Drugs
azithromycin
03
Conditions
primary ciliary dyskinesia (PCD)
Beyond the preview
Go deeper on 2013-004664-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004664-58.